Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bi-weekly Cetuximab Combined With FOLFOX-6 as First-line Treatment in Metastatic Colorectal Cancer Patients With Wild-type K-ras Status

NCT01051167 is registered in ClinicalTrials.gov with Martin Schuler, Prof. Dr. med. as lead sponsor.

NCT NCT01051167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01051167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bi-weekly Cetuximab Combined With FOLFOX-6 as First-line Treatment in Metastatic Colorectal Cancer Patients With Wild-type K-ras Status
Lead sponsor
Martin Schuler, Prof. Dr. med.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
September 30, 2016
Enrollment
59 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer